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Cardiac excitation-contraction (EC)
coupling is a process which governs con-
tractility of the heart through the con-
trolled release of Ca2C from the
sarcoplasmic reticulum (SR). The type-2
ryanodine receptor (RyR2) is the route
through which Ca2C is released from the
SR providing the necessary driving force
for cellular contraction. In heart failure,
RyR2-channels become abnormally active,
or ‘leaky’, and are unable to remain closed
during diastole resulting in unwanted
irregular contractile and electrical activ-
ity.1 Defective Zn2C handling has been
shown to contribute to the cellular pathol-
ogy of certain cardiomyopathies which
give rise to impaired contractility includ-
ing heart failure.2 This is likely a conse-
quence of altered EC coupling as a result
of modified RyR2 function. How zinc
impacts upon the contractile force and the
release of calcium from intracellular stores
in heart is not fully understood.
In the recent study by Woodier and co-
workers3 it was shown that cytosolic Zn2C
can act as a high affinity activator of
RyR2. In the aforementioned study, single
RyR2 channels were incorporated into
phospholipid bilayers under voltage-
clamp conditions and the direct action of
Zn2C at the cytosolic face of the channel
studied. This approach enabled the study
of RyR2 function under tight control of
the chemical environment. Concentra-
tions of free Zn2C  1 nM potentiated
RyR2 activity but the presence of activat-
ing levels of cytosolic Ca2C was a require-
ment for channel activation. At
concentrations of free Zn2C > 1 nM, the
main activating ligand became Zn2C and
the requirement of Ca2C for channel acti-
vation was removed. Under these condi-
tions channel gating was altered and RyR2
gated in exceptionally long-lived open
states. The ability of Zn2C at a
concentration of 1 nM to directly activate
RyR2 reveals that RyR2 has a much
higher affinity for Zn2C than Ca2C (by
»3-orders of magnitude). These data sug-
gest that RyR2-mediated Ca2C-homeosta-
sis is intimately related to intracellular
Zn2C levels. Woodier et al. also showed
that Zn2C modulated both the frequency
and amplitude of Ca2C-waves in cardio-
myocytes in a concentration-dependent
manner.3 Reduction of the concentration
of intracellular Ca2C to sub-activating
concentrations did not abolish Ca2C-
waves in the presence of 1 nM Zn2C. This
suggests that RyR2 gating is altered under
these conditions whereby RyR2 gates in a
Ca2C-independent manner with Zn2C the
sole activating ligand. These data indicate
that channel dysregulation, through aber-
rant Zn2C homeostasis, may play a funda-
mental role in the generation of heart
failure and other arrhythmic diseases.
Cardiomyocytes contain a small but
measurable pool of free Zn2C in the cyto-
sol reported to be »100 pM.4 Since small
changes in the Zn2C level will have a
marked effect on RyR2 activity, this
becomes highly relevant when we consider
that concentrations of Zn2C have recently
been reported to be transiently elevated to
»50 nM during Zn2C-signaling events.5
Live-cell detection of intracellular Zn2C
and Ca2C using selective fluorophores
reveal that intracellular Zn2C concentra-
tions are altered during cardiac EC cou-
pling and that spatio-temporal
fluctuations in free Zn2C levels are compa-
rable to those of Ca2C.6 Extracellular
Zn2C can also enter cardiomyocytes
through the L-type Ca2C channel in a sim-
ilar manner to Ca2C.7 These Zn2C fluctu-
ations may serve to modulate RyR2
activity highlighting a potential role for
Zn2C in fine-tuning graded Ca2C-release
events to control the force and duration of
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cardiac contractions. Under certain patho-
physiological conditions including heart
failure, diabetes and ischemia, concentra-
tions of intracellular Zn2C are chronically
elevated and are reported to be in the high
nanomolar range (c.a. 30 nM).2,8 Under
such conditions RyR2 will decouple from
the regulatory effects of cytosolic Ca2C
and be under control of Zn2C. This may
contribute toward abnormally high RyR2
channel activity which is associated with
heart failure and fatal arrhythmias.
The role of Zn2C as a high affinity
activator of RyR2 able to modulate
channel function in the absence of Ca2C
represents a paradigm shift in our under-
standing of how RyR2 is activated during
EC coupling. These new data
provide a plausible mechanistic explana-
tion linking Zn2C dyshomeostasis to cer-
tain cardiomyopathies characterized by
defective contractility and dysregulated
Ca2C-responses (Fig. 1). However, in
order to substantiate a model for inte-
grated Zn2C-signaling in the heart, a
more detailed understanding of the
molecular mechanism by which Zn2C
modulates RyR2 function is required and
the further impact this has on cardiac
function needs to be examined. Determin-
ing the origin of Zn2C fluxes during
the cardiac contraction-relaxation cycle
in both health and disease states will also
be crucial in advancing our understanding
of how cellular Zn2C shapes EC coupling.
Understanding Zn2C signaling in the
heart and unveiling new mechanisms
involved in regulating intracellular
Ca2C dynamics in cardiac tissue may
highlight potential new drug targets in the
fight against heart failure and fatal
arrhythmias.
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Figure 1. A model to show how zinc may regulate RyR2-mediated sarcoplasmic reticulum calcium release. Physiological conditions: During the resting
phase of the cardiac cycle RyR2 is closed as the cytosolic [Ca2C] is sub-activating (100 nM). The normal trigger for RyR2 activation during systole is a tran-
sient rise in [Ca2C] ( 1 mM). Zn2C-dyshomeostasis: If the intracellular [Zn2C] rises >1 nM, the dependency on Ca2C for RyR2 openings is removed and
Zn2C becomes the activating ligand. This leads to abnormally active channels.
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